Baxter Operating Margin 2006-2019 | BAX

Current and historical operating margin for Baxter (BAX) over the last 10 years. The current operating profit margin for Baxter as of December 31, 2019 is 15.31%.
Baxter Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2019-12-31 $11.36B $1.77B 15.60%
2019-09-30 $11.14B $1.63B 14.61%
2019-06-30 $11.05B $1.51B 13.64%
2019-03-31 $11.05B $1.54B 13.90%
2018-12-31 $11.10B $1.58B 14.27%
2018-09-30 $11.08B $1.49B 13.42%
2018-06-30 $11.02B $1.40B 12.74%
2018-03-31 $10.79B $1.37B 12.67%
2017-12-31 $10.58B $1.29B 12.17%
2017-09-30 $10.43B $1.30B 12.49%
2017-06-30 $10.28B $1.19B 11.56%
2017-03-31 $10.26B $0.91B 8.87%
2016-12-31 $10.16B $0.75B 7.33%
2016-09-30 $10.12B $0.62B 6.13%
2016-06-30 $10.05B $0.53B 5.23%
2016-03-31 $9.94B $0.55B 5.48%
2015-12-31 $9.97B $0.45B 4.50%
2015-09-30 $10.15B $0.46B 4.55%
2015-06-30 $10.38B $0.59B 5.66%
2015-03-31 $12.06B $1.16B 9.61%
2014-12-31 $13.50B $1.74B 12.88%
2014-09-30 $15.03B $2.09B 13.93%
2014-06-30 $16.03B $2.53B 15.79%
2014-03-31 $15.55B $2.70B 17.36%
2013-12-31 $15.15B $2.74B 18.11%
2013-09-30 $14.33B $2.72B 18.99%
2013-06-30 $14.09B $2.84B 20.17%
2013-03-31 $14.00B $2.79B 19.95%
2012-12-31 $13.94B $2.77B 19.88%
2012-09-30 $14.03B $2.87B 20.47%
2012-06-30 $14.03B $2.84B 20.24%
2012-03-31 $14.00B $2.89B 20.68%
2011-12-31 $13.89B $2.95B 21.20%
2011-09-30 $13.80B $2.84B 20.61%
2011-06-30 $13.54B $2.88B 21.27%
2011-03-31 $13.20B $2.75B 20.82%
2010-12-31 $12.84B $2.14B 16.63%
2010-09-30 $12.82B $2.35B 18.31%
2010-06-30 $12.74B $2.30B 18.03%
2010-03-31 $12.67B $2.35B 18.52%
2009-12-31 $12.56B $2.88B 22.90%
2009-09-30 $12.22B $2.85B 23.28%
2009-06-30 $12.23B $2.72B 22.27%
2009-03-31 $12.30B $2.68B 21.79%
2008-12-31 $12.35B $2.56B 20.76%
2008-09-30 $12.23B $2.47B 20.22%
2008-06-30 $11.83B $2.37B 20.06%
2008-03-31 $11.47B $2.26B 19.75%
2007-12-31 $11.26B $2.24B 19.87%
2007-09-30 $11.02B $2.15B 19.52%
2007-06-30 $10.82B $2.14B 19.81%
2007-03-31 $10.64B $1.98B 18.57%
2006-12-31 $10.38B $1.84B 17.74%
2006-09-30 $10.11B $1.74B 17.26%
2006-06-30 $9.95B $1.63B 16.35%
2006-03-31 $9.88B $1.57B 15.85%
2005-12-31 $9.85B $1.53B 15.53%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $41.301B $11.362B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.105B 24.52
Medtronic (MDT) Ireland $115.616B 15.54
Stryker (SYK) United States $55.501B 17.93
Boston Scientific (BSX) United States $43.519B 19.60
Coloplast (CLPBY) Denmark $32.381B 49.97
Lonza Group Ag (LZAGY) Switzerland $30.517B 0.00
Terumo (TRUMY) Japan $24.814B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $23.088B 0.00
ResMed (RMD) United States $22.122B 38.44
Zimmer Biomet Holdings (ZBH) United States $18.991B 11.69
Smith & Nephew SNATS (SNN) United Kingdom $14.868B 0.00
Sunny Optical Technology (SNPTF) China $14.665B 0.00
Bio-Rad Laboratories (BIO) United States $10.946B 51.16
Insulet (PODD) United States $10.367B 634.31
William Demant Holdings (WILYY) Denmark $7.898B 0.00
Hill-Rom Holdings (HRC) United States $7.034B 20.23
DiaSorin S.p.A (DSRLF) Italy $6.994B 0.00
GN STORE NORD (GNNDY) Denmark $6.057B 0.00
Perrigo (PRGO) Ireland $6.039B 11.01
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Haemonetics (HAE) United States $4.949B 30.46
Canopy Growth (CGC) Canada $4.629B 0.00
ICU Medical (ICUI) United States $4.256B 27.80
Quidel (QDEL) United States $3.979B 34.93
Neogen (NEOG) United States $3.373B 57.14
Agios Pharmaceuticals (AGIO) United States $2.569B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $2.529B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.354B 0.00
NuVasive (NUVA) United States $2.269B 17.54
Envista Holdings (NVST) United States $2.062B 0.00
National Vision Holdings (EYE) United States $1.337B 22.53
AtriCure (ATRC) United States $1.273B 0.00
Cardiovascular Systems (CSII) United States $1.210B 0.00
Aurora Cannabis (ACB) Canada $0.986B 0.00
TG Therapeutics (TGTX) United States $0.979B 0.00
Phibro Animal Health (PAHC) United States $0.961B 19.01
NanoString Technologies (NSTG) United States $0.862B 0.00
VAREX IMAGING (VREX) United States $0.798B 16.58
DFB Healthcare Acquisitions (AHCO) United States $0.761B 0.00
Aphria (APHA) $0.754B 0.00
Cerus (CERS) United States $0.741B 0.00
Omeros (OMER) United States $0.663B 0.00
OraSure Technologies (OSUR) United States $0.639B 79.31
InMode (INMD) Israel $0.619B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.595B 35.39
PetIQ (PETQ) United States $0.582B 15.83
Quanterix (QTRX) United States $0.547B 0.00
LeMaitre Vascular (LMAT) United States $0.462B 26.00
Surmodics (SRDX) United States $0.432B 49.69
Owens & Minor (OMI) United States $0.427B 11.69
Lantheus Holdings (LNTH) United States $0.411B 9.23
Vapotherm (VAPO) United States $0.381B 0.00
Meridian Bioscience (VIVO) United States $0.363B 14.60
Zynex (ZYXI) United States $0.327B 35.61
Repro-Med Systems (KRMD) United States $0.298B 188.00
Utah Medical Products (UTMD) United States $0.292B 20.87
Organigram Holdings (OGI) Canada $0.280B 0.00
MacroGenics (MGNX) United States $0.257B 0.00
Cytosorbents (CTSO) United States $0.236B 0.00
BioLife Solutions (BLFS) United States $0.201B 123.00
Female Health (VERU) United States $0.196B 0.00
HEXO (HEXO) $0.192B 0.00
Viemed Healthcare (VMD) United States $0.164B 18.52
Exagen (XGN) United States $0.162B 0.00
United Health Products (UEEC) United States $0.132B 0.00
Evolus (EOLS) United States $0.130B 0.00
Rockwell Medical (RMTI) United States $0.124B 0.00
Bovie Medical (APYX) United States $0.122B 0.00
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.110B 0.00
Liberty Health Sciences (LHSIF) Canada $0.105B 0.00
Fonar (FONR) United States $0.093B 6.78
Chimerix (CMRX) United States $0.082B 0.00
Brainsway (BWAY) Israel $0.080B 0.00
MTech Acquisition (KERN) United States $0.069B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.062B 0.00
United-Guardian (UG) United States $0.061B 12.69
Nephros (NEPH) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
Surface Oncology (SURF) United States $0.047B 0.00
GUARDION HEALTH (GHSI) United States $0.037B 0.00
ImmuCell (ICCC) United States $0.030B 0.00
FSD PHARMA INC (HUGE) Canada $0.024B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
Capricor Therapeutics (CAPR) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00